TITLE

Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission

AUTHOR(S)
Pijnenburg, M. W.; Hofhuis, W.; Hop, W. C.; Jongste, J. C. De.
PUB. DATE
March 2005
SOURCE
Thorax;Mar2005, Vol. 60 Issue 3, p215
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Nitric oxide in exhaled air (FENO) is a marker of eosinophilic airway inflammation. A study was undertaken to determine whether FENO predicts asthma relapse in asymptomatic asthmatic children in whom inhaled corticosteroids are discontinued. Methods: Forty children (21 boys) of mean age 12.2 years on a median dose of 400 μg budesonide or equivalent (range 100-400) were included. FENO was measured before and 2, 4, 12, and 24 weeks after withdrawal of steroids. A relapse was defined as more than one exacerbation per month, or need for β agonist treatment on 4 days per week for at least 2 weeks, or diurnal peak How variability of >20%. FENO measurements were performed online with an expiratory flow of 50 ml/s. Results: Nine patients relapsed. Two and 4 weeks after withdrawal of steroids geometric mean FENO in children who were about to relapse was higher than in those who did not relapse: 35.3 ppb v 15.7 ppb at 2 weeks (ratio 2,3; 95% CI .2 to 4.1; p=0.01) and 40.8 ppb v 15.9 ppb at 4 weeks (ratio 2.6; 95% CI 1.3 to 5.1). An FENO value of 49 ppb at 4 weeks after discontinuation of steroids had the best combination of sensitivity (71%) and specificity (93%) for asthma relapse. Conclusion: FENO 2 and 4 weeks after discontinuation of steroids in asymptomatic asthmatic children may be an objective predictor of asthma relapse.
ACCESSION #
16455990

 

Related Articles

  • Magnesium and Outcomes in Children with Acute Asthma. Sadovsky, Richard // American Family Physician;6/15/2001, Vol. 63 Issue 12, p2441 

    Presents information on a study by R.J. Scarfone and others that studied the early administration of magnesium to moderately to severely ill children with asthma in a randomized, double-blind, placebo-controlled clinical trial. Description of the study and its results; Conclusion that among a...

  • Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Payne, D. N. R.; Qiu, Y.; Zhu, J.; Peachey, L.; Scallan, M.; Bush, A.; Jeffery, P. K. // Thorax;Oct2004, Vol. 59 Issue 10, p862 

    Background: The effective management and development of new treatments for children with difficult asthma requires investigation of the underlying airway pathology and its relationships with persistent symptoms and airflow limitation. Methods: The density of immunologically distinct inflammatory...

  • APRECIERI ASUPRA EFECTELOR ADVERSE ALE CORTICOSTEROIZILOR INHALATORI ADMINISTRAÅ¢I ÃŽN DOZE MICI LA COPIII ASTMATICI. MOHOR, C. // Acta Medica Transilvanica;dec2012, Vol. 17 Issue 4, p103 

    The way in which inhaled corticosteroids influence the growth and the development of the children with asthma is relatively little studied, the results being often contradictory. The study was conducted on two hundred subjects with one hundred children with asthma treated with inhaled...

  • Salmeterol (Serevent) asthma trial halted early. Wooltorton, Eric // CMAJ: Canadian Medical Association Journal;3/18/2003, Vol. 168 Issue 6, p738 

    Discusses the concerns that the drug Serevent might be associated with life-threatening asthma episodes and asthma-related deaths. Controversy about the safety of long-acting Î’-receptor agonists (LABA); Assessment of white and black patients who used inhaled corticosteroids at baseline;...

  • Editorial [Guest Editor: Strategies for the Improvement of Asthma Therapy (Executive Editor: Andreas Pahl)]. Pahl, Andreas // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3173 

    Asthma bronchiale, affecting 155 millions people worldwide, has emerged as a major public health problem worldwide over the past 20 years. Although data indicate that current asthma therapies led to limited decreases in death rates, it continues to be a significant health care problem. As we...

  • Product briefs.  // Biomedical Business & Technology;Jun2008, Vol. 31 Issue 6, p36 

    The article reports that Apieron has begun shipments of its Insight eNO system that provides office-based measurements of exhaled nitric oxide (eNO). eNO is an indicator of airway inflammation and asthma control. eNO measurements allow physicians to adjust inhaled corticosteroid therapy in...

  • Management of asthma in children. Townshend, J.; Hails, S.; Mckean, M. // BMJ: British Medical Journal (International Edition);8/4/2007, Vol. 335 Issue 7613, p253 

    The article presents an overview of the management of asthma in children. A discussion of what the acute managemnt of asthma, long term management of atopic asthma and episodic viral wheeze is is presented. The benefits and disadvantages of the use of corticosteroids and long acting beta...

  • Difficult asthma in children. McKenzie, S. A.; Bush, A. // Thorax;Oct2002, Vol. 57 Issue 10, p915 

    One study of computerised prescribing databases showed that fewer than one in six parents were collecting sufficient prescriptions to cover regular prophylactic asthma medication for their children. Asthmatic children on high dose corticosteroids need to be fully assessed to ensure that such...

  • Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis. Leung, T. F.; Wong, G. W. K.; Ko, F. W. S.; Lam, C. W. K.; Fok, T. F. // Thorax;Oct2005, Vol. 60 Issue 10, p822 

    Background: Recent studies have repeatedly shown weak correlations among lung function parameters, atopy, exhaled nitric oxide level (FeNO), and airway inflammatory markers, suggesting that they are non- overlapping characteristics of asthma in adults. A study was undertaken to determine, using...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics